LC28-0126
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for LC28-0126, covering 2014-03-14 to 2018-04-11. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetic Characteristics of LC28-0126. [Phase 1]